Diverse Effects of Exosomes on COVID-19: A Perspective of Progress From Transmission to Therapeutic Developments

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a new strain of coronavirus and the causative agent of the current global pandemic of coronavirus disease 2019 (COVID-19). There are currently no FDA-approved antiviral drugs for COVID-19 and there is an urgent need to develop treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Gurunathan, Sangiliyandi, Kang, Min Hee, Kim, Jin-Hoi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8355618/
https://www.ncbi.nlm.nih.gov/pubmed/34394121
http://dx.doi.org/10.3389/fimmu.2021.716407

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8355618/
https://www.ncbi.nlm.nih.gov/pubmed/34394121
http://dx.doi.org/10.3389/fimmu.2021.716407

Ejemplares similares